Literature DB >> 8663398

Proteolytic processing patterns of prosaposin in insect and mammalian cells.

T Leonova1, X Qi, A Bencosme, E Ponce, Y Sun, G A Grabowski.   

Abstract

Prosaposin is a multifunctional protein encoded at a single locus in humans and mice. The precursor contains, in tandem, four glycoprotein activators or saposins, termed A, B, C, and D, that are essential for specific glycosphingolipid hydrolase activities. Prosaposin appears to be a potent neurotrophic factor. To explore the proteolytic processing from prosaposin to mature activator proteins, metabolic labeling was done with human prosaposin expressed in insect cells, human fibroblasts, neuronal stem cells (NT2) and retinoic acid-differentiated NT2 neurons. In all cell types, the major processing pathway was through a tetrasaposin, A-B-C-D, from which saposin A was then removed. In mammalian cells monosaposins were derived from the trisaposin B-C-D by cleavage to the disaposins, B-C and C-D, that were processed to monosaposins. In insect cells the major end products were the disaposins, with A-B and C-D derived from the tetrasaposin, A-B-C-D, or with B-C and C-D derived from the trisaposin, B-C-D. In insect and mammalian cells, the nonsignal NH2-terminal peptide preceding saposin A (termed Nter) was usually removed prior to saposin A cleavage. In NT2-derived differentiated neurons, precursor tetrasaposins containing A-B-C-D were secreted with and without Nter. Immunofluorescence studies using prosaposin-specific antisera showed large steady state amounts of uncleaved prosaposin in Purkinje cells, cortical neurons, and other specific cell types in adult mice. These studies indicate that prosaposin processing is highly regulated at a proteolytic level to produce prosaposin, tetrasaposins, or mature monosaposins in specific mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663398     DOI: 10.1074/jbc.271.29.17312

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Analyses of temporal regulatory elements of the prosaposin gene in transgenic mice.

Authors:  Ying Sun; David P Witte; Peng Jin; Gregory A Grabowski
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators.

Authors:  L Madar-Shapiro; M Pasmanik-Chor; T Dinur; A Dagan; S Gatt; M Horowitz
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 3.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

4.  The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.

Authors:  Tsadok Cohen; Wojtek Auerbach; Liat Ravid; Jacques Bodennec; Amos Fein; Anthony H Futerman; Alexandra L Joyner; Mia Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation.

Authors:  Madanan Madathiparambil Gopalakrishnan; Hans-Wilhelm Grosch; Silvia Locatelli-Hoops; Norbert Werth; Eva Smolenová; Michael Nettersheim; Konrad Sandhoff; Andrej Hasilik
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

6.  Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.

Authors:  Ying Sun; Matt Zamzow; Huimin Ran; Wujuan Zhang; Brian Quinn; Sonya Barnes; David P Witte; Kenneth D R Setchell; Michael T Williams; Charles V Vorhees; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2013-02-27       Impact factor: 6.150

7.  Posttranslational regulation of surfactant protein B expression.

Authors:  Susan Guttentag
Journal:  Semin Perinatol       Date:  2008-10       Impact factor: 3.300

8.  Isolation of proliferation factor of immature T-cell clone in concanavalin A-stimulated splenocyte culture supernatant.

Authors:  Yasuhiro Kohama; Shinji Shinoda; Katsunobu Hagihara; Takeshi Hashimoto; Asuka Yamaguchi; Akihiro Nakamura; Takahiro Tsuchiya; Kazutake Tsujikawa; Hiroshi Yamamoto
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

9.  Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.

Authors:  Ying Sun; Benjamin Liou; Huimin Ran; Matthew R Skelton; Michael T Williams; Charles V Vorhees; Kazuyuki Kitatani; Yusuf A Hannun; David P Witte; You-Hai Xu; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2010-01-04       Impact factor: 6.150

10.  Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.

Authors:  Ying Sun; Huimin Ran; Matt Zamzow; Kazuyuki Kitatani; Matthew R Skelton; Michael T Williams; Charles V Vorhees; David P Witte; Yusuf A Hannun; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.